Advertisement
Screener

Summit Therapeutics Inc. (SMMT) Net Margin

Summit Therapeutics Inc. (SMMT) Net Margin

  • 2022-09-30: Net Margin -9720.45%.
  • 2022-06-30: Net Margin -7136.60%.
  • 2022-03-31: Net Margin -8558.80%.
  • 2021-12-31: Net Margin -10796.41%.

Complete source-backed net margin history.

Available history
2019-01-31 to 2022-12-31
Data captured

Historical Net Margin

DateNet Margin
2022-09-30-9720.45%
2022-06-30-7136.60%
2022-03-31-8558.80%
2021-12-31-10796.41%
2021-09-30-1497.25%
2021-06-30-42835.09%
2021-03-31-9108.33%
2020-12-31-7319.46%
2020-09-30-9802.76%
2020-06-30-8987.65%
2020-03-31-1893.21%
2019-09-30-4308.11%

Annual Net Margin

DateNet Margin
2022-12-31-11174.75%
2021-12-31-4897.84%
2020-12-31-6127.56%
2019-12-31-3920.19%
2019-01-3119.04%

Similar stocks

Stock NameCountryMarket CapPE Ratio
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52